Brind.

Veterinary Drugmaker Selmore Pharmaceuticals Announces IPO on PSX Main Board

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Selmore Pharmaceuticals Ltd., a veterinary drugmaker, has published a draft prospectus seeking a listing on the Pakistan Stock Exchange’s Main Board. The proposed initial public offering involves 48.61 million ordinary shares, with public comments invited until October 5, 2026.

From propakistani.pk

Why it matters

Some supportBrind's analysis of the reports

The IPO aims to raise between Rs. 2.04 billion and Rs. 3.06 billion, depending on the final pricing. The company plans to use the proceeds to establish a new veterinary pharmaceutical formulation plant and its first Active Pharmaceutical Ingredients (API) manufacturing facility.

From propakistani.pk

Who's involved

  • LahoreVeterinary drug manufacturing company seeking public capital.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped